UPL announced on Monday that the company has completed the acquisition of Yoloo (Laoting) Bio-technology which was announced on November 14, 2019.

 

“The Company hereby confirms the completion of the acquisition of Yoloo (Laoting) Bio-technology Co. Ltd., that was announced on November 14, 2019, post all customary and regulatory approvals and the transaction is closed,” UPL said in the press note.

 

Yoloo Laoting has more than 100 product registrations, about 1200 distributor contacts, and 240+ employees. 

 

UPL will gain from Laoting Yoloo's broad distribution base, product registrations and access to the Chinese domestic market creating a strong footprint for growth in China. The company also intends to

optimize Laoting Yoloo's manufacturing facilities to augment its global production capabilities. UPL will build on the relationships that Laoting Yoloo has cultivated and serve their customers with a wider portfolio.